Indies Pharma Jamaica Limited (JMSE:INDIES)

Jamaica flag Jamaica · Delayed Price · Currency is JMD
2.510
-0.190 (-7.04%)
At close: Apr 27, 2026
-25.52%
Market Cap 3.34B
Revenue (ttm) 1.08B
Net Income (ttm) 128.86M
Shares Out 1.33B
EPS (ttm) 0.10
PE Ratio 26.13
Forward PE n/a
Dividend 0.14 (5.00%)
Ex-Dividend Date Apr 9, 2026
Volume 44,790
Average Volume 167,084
Open n/a
Previous Close 2.700
Day's Range 2.510 - 2.800
52-Week Range 2.330 - 3.400
Beta 0.13
RSI 30.04
Earnings Date Jun 12, 2026

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2003
Employees 64
Stock Exchange Jamaica Stock Exchange
Ticker Symbol INDIES
Full Company Profile

Financial Performance

In fiscal year 2025, Indies Pharma Jamaica's revenue was 1.13 billion, a decrease of -2.82% compared to the previous year's 1.16 billion. Earnings were 181.29 million, a decrease of -18.04%.

Financial Statements

News

There is no news available yet.